ChemicalBook > Product Catalog >API >Circulatory system drugs >Antihypertensive drugs >FLOSEQUINAN

FLOSEQUINAN

FLOSEQUINAN Suppliers list
Company Name: Shaanxi Dideu Medichem Co. Ltd
Tel: +86-029-89586680 +86-18192503167
Email: 1026@dideu.com
Products Intro: Product Name:FLOSEQUINAN USP/EP/BP
CAS:76568-02-0
Purity:99.9% Package:25kgs/Drum;200kgs/Drum Remarks:FDA GMP CEP Approved Manufacturer
Company Name: Dideu Industries Group Limited
Tel: +86-29-89586680 +86-15129568250
Email: 1026@dideu.com
Products Intro: Product Name:FLOSEQUINAN
CAS:76568-02-0
Purity:99.9% Package:1g;1.1USD Remarks:FDA GMP CEP Approved Manufacturer
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:Flosequinan
CAS:76568-02-0
Package:1 mg;10 mg;100 mg;200 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: LGM Pharma  
Tel: 1-(800)-881-8210
Email: inquiries@lgmpharma.com
Products Intro: Product Name:Flosequinan
CAS:76568-02-0
Purity:Typically NLT 98%
Company Name: Shanghai Worldyang Chemical Co.,Ltd.  
Tel: 021-021-56795766
Email: sales@worldyachem.com
Products Intro: Product Name:FLOSEQUINAN
CAS:76568-02-0
Purity:98% Package:10g;50g;100g;500g;1Kg;5Kg;10Kg;25Kg

FLOSEQUINAN manufacturers

  • FLOSEQUINAN USP/EP/BP
  • FLOSEQUINAN USP/EP/BP pictures
  • $1.10 / 1g
  • 2021-08-11
  • CAS:76568-02-0
  • Min. Order: 1g
  • Purity: 99.9%
  • Supply Ability: 100 Tons min
  • Flosequinan
  • Flosequinan pictures
  • $0.00 / 1KG
  • 2020-05-10
  • CAS:76568-02-0
  • Min. Order: 1KG
  • Purity: 99.0%
  • Supply Ability: 500 MT
FLOSEQUINAN Basic information
Product Name:FLOSEQUINAN
Synonyms:BTS-49465;Flosequinon;Manoplax;7-Fluoro-1-methyl-3-(methylsulfinyl)-4(1H)-quinolinone;7-Fluoro-1-methyl-3-methylsulfinylquinolin-4(1H)-one;FLOSEQUINAN;7-Huom-1-methyl-3-(methylsulfinyl)-4(1H)-quinolinone;FLOSEQUINAN USP/EP/BP
CAS:76568-02-0
MF:C11H10FNO2S
MW:239.27
EINECS:
Product Categories:
Mol File:76568-02-0.mol
FLOSEQUINAN Structure
FLOSEQUINAN Chemical Properties
Melting point 226-228°
Boiling point 423.1±45.0 °C(Predicted)
density 1.44±0.1 g/cm3(Predicted)
storage temp. 2-8°C
pka-0.51±0.70(Predicted)
Safety Information
MSDS Information
FLOSEQUINAN Usage And Synthesis
DescriptionFlosequinan is a new mixed arteriolar and venous vasodilator useful for the treatment of patients with congestive heart failure with or without ACE inhibitors, but especially in those patients who are intolerant to ACE inhibitors. It does not cause reflex stimulation of the renin-angiotensin or sympathetic nervous system. How flosequinan achieves its direct vasodilating effect is not clear, it is thought to interfere with protein kinase C and the production of inositol triphosphate. Flosequinan is well absorbed orally, and with the relatively long half-life of its sulfone metabolite it is suitable for once a day administration.
OriginatorBoots (United Kingdom)
UsesAntihypertensive (vasodilator).
DefinitionChEBI: Flosequinan is a member of quinolines.
Manufacturing Process7-Fluoro-3-methylsulphinyl-4-quinolone (5.0 g) was dissolved in hot butanone (250 ml) containing anhydrous potassium carbonate (3.06 g). The resulting suspension was stirred and treated dropwise with dimethyl sulphate (2.09 ml). The mixture was stirred and boiled under reflux for 1 hour and filtered while hot. The filtrate was allowed to cool, giving a crystalline product. The product was collected and dried to give 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone, melting point 226-228°C.
The intermediate 7-fluoro-3-methylsulphinyl-4-quinolone, was prepared in the following way:
A solution of 2-amino-4-fluorobenzoic acid (62 g) in aqueous sodium carbonate (44 g sodium carbonate in 1.6 liters water) was stirred and treated dropwise with a solution of phosgene (120 g) in toluene (500 ml) during 1.5 hours. The resulting suspension was stirred at room temperature for 24 hours. The solid product was collected by filtration, washed with water and dried to give 7-fluoro-1,2-dihydro-3,1(4H)-benzoxazine-2,4-dione; melting point 217- 219°C.
A mixture of dimethyl sulphoxide (230 ml), toluene (300 ml) and 50% w/w dispersion of sodium hydride in mineral oil (20.7 g) was heated under nitrogen at 65-70°C for 1 hour, then cooled to room temperature to form dimethylsulphoxide anion, sodium salt. The resulting suspension was stirred under nitrogen and the above benzoxazine-2,4-dione (27.5 g) was added portionwise. The resulting solution was stirred at room temperature for 15 minutes and then poured into ether (3 liters). The resulting solid was collected by filtration and dissolved in water (300 ml) and the solution acidified with glacial acetic acid to a final pH of 6.0. The solution was saturated with solid potassium carbonate. The resulting precipitate was collected, dried and recrystallised from ethanol/diethyl ether to give the novel compound 2'- amino-4'-fluoro-(2-methylsulphinyl)acetophenone, melting point 115-117°C.
This compound (14 g) was dissolved in triethyl orthoformate (160 ml) at 100°C under nitrogen. The resulting solution was treated dripwise with piperidine (7 ml). The mixture was heated with stirring at 120°C under nitrogen for 30 min allowing ethanol produced to distil off, then cooled to room temperature. The solid product was collected, dried and crystalized from ethanol using charcoal to give the 7-fluoro-3-methylsulphinyl-4-quinolone; melting point 265°C.
Brand nameManoplax
Therapeutic FunctionAntihypertensive, Vasodilator
Tag:FLOSEQUINAN(76568-02-0) Related Product Information
BTS Flosequinan sulphone FLOSEQUINAN 2-Amino-4-Fluoro Benzaldehyde